Continuous Glucose Monitoring System
Continuous Glucose Monitoring System is a medical device with 28 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 13 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
4
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
76.5%
13 of 17 finished
23.5%
4 ended early
2
trials recruiting
28
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature
ROME GS System Study
Physical Inactivity Impacts on Blood Vessel Health and Glucose Levels in an Aging Population
CGM in Icodextrin PD
PROMISE Study: An Evaluation of an Implantable Continuous Glucose Sensor up to 180 Days
Clinical Trials (28)
Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature
ROME GS System Study
Physical Inactivity Impacts on Blood Vessel Health and Glucose Levels in an Aging Population
CGM in Icodextrin PD
PROMISE Study: An Evaluation of an Implantable Continuous Glucose Sensor up to 180 Days
Characterization of the "Transfusion-dependent Prediabetes" Using Continuous Glucose Monitoring
PRECISION Study: Multi-center Study of Performance of a Novel Implanted CGM System Using a Next Generation Transmitter and Algorithm
Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features
Evaluation of Accuracy of Guardian Sensor 3 in Diabetes Patients on Peritoneal Dialysis
Association Between Time in Range and In-hospital Outcomes in Type 2 Diabetic Patients With Acute Coronary Syndrome
Development of Continuous Glucose Monitoring System Cohort for Personalized Diabetes Prevention and Management Platform
Assessment of the Efficacy of the Artificial Pancreas Combined With a Qualitative Meal Size Estimation to Control Postprandial Glucose Levels
Effectiveness and Safety of the Dexcom G6 Continuous Glucose Monitoring System in Non-Critically Ill Patients in the Inpatient Setting
Evaluation of the Safety and Effectiveness of the Dexcom Glucose Monitoring (CGM) System
Closed-loop Control of Glucose Levels (Artificial Pancreas) for 12 Days in Adults With Type 1 Diabetes
Closed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 Diabetes
The Blood Glucose Control in Patients With Type 2 Diabetes Treated With Glargine
The Effect of Continuous Glucose Monitoring on Glycemic Control and Pregnancy Outcomes in Gestational Diabetes Mellitus
Relationship Between Blood Glucose Variability and Prognosis in Critically Ill Patients
Evaluation of the Accuracy of an Implanted Glucose Sensor
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 28